An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.

Autor: Jambulingam P; ICMR-Vector Control Research Centre, Puducherry, India., Kuttiatt VS; ICMR-Vector Control Research Centre, Puducherry, India., Krishnamoorthy K; ICMR-Vector Control Research Centre, Puducherry, India., Subramanian S; ICMR-Vector Control Research Centre, Puducherry, India., Srividya A; ICMR-Vector Control Research Centre, Puducherry, India., Raju HKK; ICMR-Vector Control Research Centre, Puducherry, India., Rahi M; Indian Council of Medical Research, New Delhi, India., Somani RK; Department of Clinical Pharmacology & Therapeutics, Nizams Institute of Medical Sciences, Hyderabad, India., Suryaprakash MK; District Vector-Borne Disease Control Programme, Yadgiri, Karnataka, India., Dwivedi GP; Consultant (Project), Yamuna Vihar, Himachal Pradesh, India., Weil GJ; Washington University School of Medicine, St. Louis, Missouri, United States of America.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2021 Feb 16; Vol. 15 (2), pp. e0009069. Date of Electronic Publication: 2021 Feb 16 (Print Publication: 2021).